8-K: Current report filing
Published on March 17, 2000
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) March 14, 2000
SONUS PHARMACEUTICALS, INC.
(Exact name of Registrant as specified in its charter)
Delaware 0-26866 95-4343413
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No)
22026 20th Avenue S.E., Bothell,
Washington 98021 (Address of principal
executive offices) (Zip Code)
Registrant's telephone number, including area code (425) 487-9500
Not Applicable
(Former name or former address, if changed since last report)
Page 1 of 4
Exhibit Index on Page 4
ITEMS 1 THROUGH 4, 6, 8 AND 9 ARE NOT APPLICABLE.
ITEM 5. OTHER EVENTS
Reference is made to the press release issued to the public by the
registrant on March 14, 2000, the text of which is attached hereto as Exhibit
99.1, for a description of the events reported pursuant to this Form 8-K.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS
(a) Financial Statements
Not Applicable
(b) Pro Forma Financial Information
Not Applicable
(c) Exhibits
EXHIBIT NO. DESCRIPTION
99.1 Press Release dated March 14, 2000.
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
SONUS PHARMACEUTICALS, INC.
Date: March 17, 2000 By: /s/Richard J. Klein
-----------------------------------
Richard J. Klein
Vice President of Finance
3
EXHIBIT INDEX
EXHIBIT NO. DESCRIPTION
99.1 Press Release dated March 14, 2000.
4